Mode of action of Ipomoea Batatas (Caiapo) in type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 52, Issue 7, 2003, Pages 875-880

  Ludvik, Bernhard ^a,b   Waldhäusl, Werner ^a,b   Prager, Rudolf ^a,b   Kautzky Willer, Alexandra ^a,b   Pacini, Giovanni ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; CAIAPO; GLUCOSE; INSULIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOW DRUG DOSE; MALE; METABOLIC PARAMETERS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SWEET POTATO;

IPOMOEA BATATAS;

EID: 0042591460     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00073-8     Document Type: Article

References (24)

1. DeFronzo RA: The triumvirate: Beta-cell, muscle, liver: A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
2. Ludvik B, Nolan JJ, Baloga J, et al: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995
3. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 131:281-303, 1999
4. Turner RC: The U.K. Prospective Diabetes Study: A review. Diabetes Care 21:C35-C38, 1998 (suppl 3)
5. Bailey CJ, Path MCR, Turner RC: Metformin. N Engl J Med 333:550-554, 1995
6. Nolan JJ, Jones NP, Patwardhan R, et al: Rosiglitazone taken once daily provides effective glycaemic control in patients with type 2 diabetes mellitus. Diabet Med 17:287-294, 2000
7. Aronoff S, Rosenblatt S, Braithwaite S, et al: Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care 23:1605-1611, 2000
8. Eisenberg DM, Davis RB, Ettner SL, et al: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280:1569-1575, 1998
9. Ludvik B, Mahdjoobian K, Waldhäusl W, et al: The effect of ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: A randomized study. Diabetes Care 25:239-240, 2002
10. Gibaldi M, Perrier D: Pharmacokinetics (ed 2). New York, NY, Dekker, 1982
11. Pacini G, Tonolo G, Sambataro M, et al: Insulin sensitivity and glucose effectiveness: Minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol 274:E592-E599, 1998
12. Bergman RN: Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527, 1989
13. Kahn SE, Prigeon RL, McCulloch DSK, et al: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
14. Thomaseth K, Kautzky-Willer A, Ludvik B, et al: Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol 270:E522-E531, 1996
15. Tura A, Ludvik B, Nolan JJ, et al: Insulin and C-peptide secretion and kinetics in humans: Direct and model-based measurements during OGTT. Am J Physiol 281:E966-E974, 2001
16. Mari A, Pacini G, Murphy E, et al: A model-based method for assessing insulin sensitivity from oral glucose tolerance test. Diabetes Care 24:539-548, 2001
17. Kautzky-Willer A, Pacini G, Tura A, et al: Elevated plasma leptin in gestational diabetes. Diabetologia 44:164-172, 2001
18. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470, 1999
19. Stumvoll M, Mitrakou A, Pimenta W, et al: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301, 2000
20. Angell M, Kassirer J: Alternative medicine - The risks of untested and unregulated remedies. N Engl J Med 339:839-841, 1998
21. Sotaniemi EA, Haapakoski E, Rautio A: Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18:1373-1375, 1995
22. Vuksan V, Stavro MP, Sievenpiper JL, et al: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-1226, 2000
23. Kusano S, Abe H, Tamura H: Isolation of antidiabetic components from white-skinned sweet potato (Ipomoea batatas L). Biosci Biotechnol Biochem 65:109-114, 2001
24. Kusano S, Abe H: Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L) in obese Zucker fatty rats. Bioll Pharm Bull 23:23-26, 2000